{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T20:14:24Z","timestamp":1794773664086,"version":"4.9.1"},"reference-count":180,"publisher":"Informa UK Limited","issue":"8","funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["GAP0262"],"award-info":[{"award-number":["GAP0262"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Clinical Immunology"],"published-print":{"date-parts":[[2025,8,3]]},"DOI":"10.1080\/1744666x.2025.2543473","type":"journal-article","created":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T05:25:43Z","timestamp":1754285143000},"page":"1135-1170","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":3,"title":["Clinical efficacy and safety evaluation of drug therapies for the treatment of progressive fibrotic-interstitial lung diseases (PF-ILDs): a network meta-analysis of randomized controlled trials"],"prefix":"10.1080","volume":"21","author":[{"given":"Pooja","family":"Singh","sequence":"first","affiliation":[{"name":"Academy of Scientific and Innovative Research (AcSIR)","place":["Ghaziabad, India"]},{"name":"Council of Scientific and Industrial Research-Institute of Genomics and Integrative Biology (CSIR-IGIB)","place":["New Delhi, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5127-3054","authenticated-orcid":false,"given":"Gayathri","family":"Thampi","sequence":"additional","affiliation":[{"name":"Council of Scientific and Industrial Research-Institute of Genomics and Integrative Biology (CSIR-IGIB)","place":["New Delhi, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1404-4230","authenticated-orcid":false,"given":"Khyati","family":"Gupta","sequence":"additional","affiliation":[{"name":"Council of Scientific and Industrial Research-Institute of Genomics and Integrative Biology (CSIR-IGIB)","place":["New Delhi, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niengjolly","family":"Gangte","sequence":"additional","affiliation":[{"name":"Council of Scientific and Industrial Research-Institute of Genomics and Integrative Biology (CSIR-IGIB)","place":["New Delhi, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bijay","family":"Pattnaik","sequence":"additional","affiliation":[{"name":"All India Institute of Medical Sciences (AIIMS)","place":["New Delhi, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anurag","family":"Agrawal","sequence":"additional","affiliation":[{"name":"Ashoka University","place":["Sonepat, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritushree","family":"Kukreti","sequence":"additional","affiliation":[{"name":"Academy of Scientific and Innovative Research (AcSIR)","place":["Ghaziabad, India"]},{"name":"Council of Scientific and Industrial Research-Institute of Genomics and Integrative Biology (CSIR-IGIB)","place":["New Delhi, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,8,12]]},"reference":[{"key":"e_1_3_7_2_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00692-2018"},{"key":"e_1_3_7_3_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202202-0399ST"},{"key":"e_1_3_7_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2005230"},{"key":"e_1_3_7_5_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00085-2020"},{"key":"e_1_3_7_6_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-021-01749-1"},{"key":"e_1_3_7_7_1","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0076-2018"},{"key":"e_1_3_7_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-020-01578-6"},{"key":"e_1_3_7_9_1","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0109-2019"},{"key":"e_1_3_7_10_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-019-1022-1"},{"key":"e_1_3_7_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.74"},{"key":"e_1_3_7_12_1","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-3-8"},{"key":"e_1_3_7_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000025322"},{"key":"e_1_3_7_14_1","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0158-2019"},{"key":"e_1_3_7_15_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.10-2572"},{"key":"e_1_3_7_16_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-024-02995-9"},{"key":"e_1_3_7_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2021.07.2166"},{"key":"e_1_3_7_18_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201902-0456OC"},{"key":"e_1_3_7_19_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm5090078"},{"key":"e_1_3_7_20_1","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2019.04.62"},{"key":"e_1_3_7_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.42861"},{"key":"e_1_3_7_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-019-01178-x"},{"key":"e_1_3_7_23_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.12-2685"},{"key":"e_1_3_7_24_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8010014"},{"key":"e_1_3_7_25_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.1570"},{"key":"e_1_3_7_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(21)00173-9"},{"key":"e_1_3_7_27_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1908681"},{"key":"e_1_3_7_28_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00161-2019"},{"key":"e_1_3_7_29_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-021-01783-1"},{"key":"e_1_3_7_30_1","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.202103-342.OC"},{"key":"e_1_3_7_31_1","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.202103-343OC"},{"key":"e_1_3_7_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-014-2994-2"},{"key":"e_1_3_7_33_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d5928"},{"key":"e_1_3_7_34_1","doi-asserted-by":"publisher","DOI":"10.18637\/jss.v106.i02"},{"key":"e_1_3_7_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1186"},{"key":"e_1_3_7_36_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7414.557"},{"key":"e_1_3_7_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2017.10.005"},{"key":"e_1_3_7_38_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201807-1255ST"},{"key":"e_1_3_7_39_1","doi-asserted-by":"publisher","DOI":"10.1002\/sctm.19-0037"},{"key":"e_1_3_7_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1843.2012.02132.x"},{"key":"e_1_3_7_41_1","unstructured":"Clinical Trials.gov. Bethesda (MD): National Library of medicine (US). 2000 Feb 29\u2013. Identifier NCT06037408 the effect of N115 on coughing in IPF patients. 2023 Aug 15 [cited 2025 Jun 17]. Available from: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT06037408"},{"key":"e_1_3_7_42_1","unstructured":"Clinical Trials.gov. Bethesda (MD): National Library of medicine (US). 2000 Feb 29\u2013. Identifier NCT03832946 a study to test the efficacy and safety of inhaled GB0139 in subjects with idiopathic pulmonary fibrosis (IPF). 2019 Feb 19 [cited 2025 Jun 17]. Available from: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT03832946"},{"key":"e_1_3_7_43_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2414108"},{"key":"e_1_3_7_44_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.5355"},{"issue":"1","key":"e_1_3_7_45_1","first-page":"103","article-title":"Efficacy and safety of traditional Chinese medicine in patients with acute exacerbation of idiopathic pulmonary fibrosis: study protocol for randomized, controlled, exploratory clinical trial","volume":"2022","author":"Li J","year":"2022","unstructured":"Li J, Zhang H, Guo W, et al. Efficacy and safety of traditional Chinese medicine in patients with acute exacerbation of idiopathic pulmonary fibrosis: study protocol for randomized, controlled, exploratory clinical trial. BMC. 2022;2022(1):103.","journal-title":"BMC"},{"key":"e_1_3_7_46_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1053356"},{"key":"e_1_3_7_47_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01794-2022"},{"key":"e_1_3_7_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(21)00354-4"},{"key":"e_1_3_7_49_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2201737"},{"key":"e_1_3_7_50_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202112-2824OC"},{"key":"e_1_3_7_51_1","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.202102-108OC"},{"key":"e_1_3_7_52_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2018-000397"},{"key":"e_1_3_7_53_1","doi-asserted-by":"publisher","DOI":"10.19852\/j.cnki.jtcm.2020.04.017"},{"key":"e_1_3_7_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(19)30262-0"},{"key":"e_1_3_7_55_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02559-2020"},{"key":"e_1_3_7_56_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02442-2019"},{"key":"e_1_3_7_57_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.22960"},{"key":"e_1_3_7_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(19)30255-3"},{"key":"e_1_3_7_59_1","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2018-212102"},{"key":"e_1_3_7_60_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01130-2018"},{"key":"e_1_3_7_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2018.08.1058"},{"key":"e_1_3_7_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(18)30181-4"},{"key":"e_1_3_7_63_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.6129"},{"key":"e_1_3_7_64_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201704-0784OC"},{"key":"e_1_3_7_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(16)30421-0"},{"key":"e_1_3_7_66_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00850-2015"},{"key":"e_1_3_7_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0254-6272(16)30058-9"},{"key":"e_1_3_7_68_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01558-2014"},{"key":"e_1_3_7_69_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1401739"},{"key":"e_1_3_7_70_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402584"},{"key":"e_1_3_7_71_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402582"},{"key":"e_1_3_7_72_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2466-14-86"},{"key":"e_1_3_7_73_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-158-9-201305070-00003"},{"key":"e_1_3_7_74_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00104612"},{"key":"e_1_3_7_75_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201202-0314OC"},{"key":"e_1_3_7_76_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1113354"},{"key":"e_1_3_7_77_1","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2012-202403"},{"key":"e_1_3_7_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60405-4"},{"key":"e_1_3_7_79_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201011-1874OC"},{"key":"e_1_3_7_80_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1843.2011.01955.x"},{"key":"e_1_3_7_81_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1103690"},{"key":"e_1_3_7_82_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1002110"},{"key":"e_1_3_7_83_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200906-0964OC"},{"key":"e_1_3_7_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60551-1"},{"key":"e_1_3_7_85_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00408-009-9209-8"},{"key":"e_1_3_7_86_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200709-1446OC"},{"key":"e_1_3_7_87_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200705-732OC"},{"key":"e_1_3_7_88_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa042976"},{"key":"e_1_3_7_89_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200404-571OC"},{"key":"e_1_3_7_90_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030511"},{"key":"e_1_3_7_91_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200312-1670OC"},{"key":"e_1_3_7_92_1","unstructured":"Clinical Trials.gov [Internet]. Bethesda (MD): National Library of medicine (US). 2000 Feb 29\u2013. Identifier NCT03287414 study of pharmacodynamics pharmacokinetics safety and tolerability of VAY736 in patients with idiopathic pulmonary fibrosis. 2017 Sep 12 [cited 2024 Apr 30]. Available from: https:\/\/clinicaltrials.gov\/show\/NCT03287414"},{"key":"e_1_3_7_93_1","unstructured":"Clinical Trials.gov. Bethesda (MD): National Library of medicine (US). 2000 Feb 29\u2013. Identifier NCT03538301 a phase 2 study to evaluate the safety biological activity and PK of ND-L02-s0201 in subjects with IPF. 2018 May 02 [cited 2024 Apr 30]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/results\/NCT03538301"},{"key":"e_1_3_7_94_1","unstructured":"Clinical Trials.gov [Internet]. Bethesda (MD): National Library of medicine (US). 2000 Feb 29\u2013. Identifier NCT01371305 STX-100 in patients with idiopathic pulmonary fibrosis (IPF). 2011 Jun 03 [cited 2024 Apr 30]. Available from: https:\/\/clinicaltrials.gov\/show\/NCT01371305"},{"key":"e_1_3_7_95_1","unstructured":"Clinical Trials.gov [Internet]. Bethesda (MD): National Library of medicine (US). 2000 Feb 29\u2013. Identifier NCT01969409 autoantibody reduction therapy in patients with idiopathic pulmonary fibrosis ART-IPF. 2013 Oct 17 [cited 2024 Apr 30]. Available from: https:\/\/clinicaltrials.gov\/show\/NCT01969409"},{"key":"e_1_3_7_96_1","doi-asserted-by":"publisher","DOI":"10.1089\/jamp.2023.0014"},{"key":"e_1_3_7_97_1","unstructured":"Clinical Trials.gov. Bethesda (MD): National Library of medicine (US). 2000 Feb 29\u2013. Identifier NCT02036580 D2212C00002 J-Phase II study. 2014 Jan 13 [cited 2024 Apr 30]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/results\/NCT02036580"},{"key":"e_1_3_7_98_1","unstructured":"Clinical Trials.gov. Bethesda (MD): National Library of medicine (US). 2000 Feb 29\u2013. Identifier NCT02846324 study to evaluate the safety and tolerability of GBT440 administered to subjects with IPF. 2016 Jul 07 [cited 2024 Apr 30]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/results\/NCT02846324"},{"key":"e_1_3_7_99_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.8693"},{"key":"e_1_3_7_100_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202403-0636OC"},{"key":"e_1_3_7_101_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202405-0977OC"},{"key":"e_1_3_7_102_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202401-0116OC"},{"key":"e_1_3_7_103_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202310-1907OC"},{"key":"e_1_3_7_104_1","unstructured":"Clinical Trials.gov. Bethesda (MD): National Library of medicine (US). 2000 Feb 29\u2013. Identifier NCT04419558 zephyrus II: efficacy and safety study of pamrevlumab in participants with idiopathic pulmonary fibrosis (IPF). 2020 Sep 30 [cited 2025 Jun 17]. Available from: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT04419558"},{"key":"e_1_3_7_105_1","unstructured":"Clinical Trials.gov. Bethesda (MD): National Library of medicine (US). 2000 Feb 29\u2013. Identifier NCT05130970 Garadacimab safety pharmacokinetics and pharmacodynamics in idiopathic pulmonary fibrosis. 2022 Jan 27 [cited 2025 Jun 17]. Available from: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT05130970"},{"key":"e_1_3_7_106_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.161.2.ats3-00"},{"key":"e_1_3_7_107_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.165.2.ats01"},{"key":"e_1_3_7_108_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.02.00492002"},{"key":"e_1_3_7_109_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.2009-040GL"},{"key":"e_1_3_7_110_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201308-1483ST"},{"key":"e_1_3_7_111_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(22)00260-0"},{"key":"e_1_3_7_112_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.42075"},{"key":"e_1_3_7_113_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-020-04565-w"},{"key":"e_1_3_7_114_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30318-0"},{"key":"e_1_3_7_115_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.191365"},{"key":"e_1_3_7_116_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1903076"},{"key":"e_1_3_7_117_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.161040"},{"key":"e_1_3_7_118_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.27466"},{"key":"e_1_3_7_119_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa055120"},{"key":"e_1_3_7_120_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.22204"},{"key":"e_1_3_7_121_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780230510"},{"key":"e_1_3_7_122_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.27584"},{"key":"e_1_3_7_123_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.38098"},{"key":"e_1_3_7_124_1","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2022-219795"},{"key":"e_1_3_7_125_1","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.25513"},{"key":"e_1_3_7_126_1","doi-asserted-by":"publisher","DOI":"10.1186\/s43168-021-00065-y"},{"key":"e_1_3_7_127_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30036-9"},{"key":"e_1_3_7_128_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.1994.tb00798.x"},{"key":"e_1_3_7_129_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.99.13613519"},{"key":"e_1_3_7_130_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.116.2.424"},{"key":"e_1_3_7_131_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2016.01.011"},{"key":"e_1_3_7_132_1","doi-asserted-by":"publisher","DOI":"10.4414\/smw.2018.14677"},{"key":"e_1_3_7_133_1","unstructured":"Clinical Trials.gov. Bethesda (MD): National Library of medicine (US). 2000 Feb 29\u2013. Identifier NCT02888080 study of efficacy safety and tolerability of ACZ885 (canakinumab) in patients with pulmonary sarcoidosis;. 2016 [cited 2024 Apr 30]. Available from: https:\/\/classic.clinicaltrials.gov\u203ashow\u203a NCT02888080"},{"key":"e_1_3_7_134_1","doi-asserted-by":"publisher","DOI":"10.36141\/svdld.v38i3.11684"},{"key":"e_1_3_7_135_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2020.12.027"},{"key":"e_1_3_7_136_1","unstructured":"Clinical Trials.gov [Internet]. National Library of Medicine (US). Identifier NCT04064242 study of efficacy safety and tolerability of ACZ885 (canakinumab) in patients with pulmonary sarcoidosis. 2016 [cited 2025 Jun 15]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT04064242"},{"key":"e_1_3_7_137_1","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2012-201962"},{"key":"e_1_3_7_138_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00408-020-00394-7"},{"key":"e_1_3_7_139_1","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2021-217976"},{"key":"e_1_3_7_140_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2015.11.013"},{"key":"e_1_3_7_141_1","doi-asserted-by":"publisher","DOI":"10.1186\/2050-6511-15-63"},{"key":"e_1_3_7_142_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9082560"},{"key":"e_1_3_7_143_1","doi-asserted-by":"publisher","DOI":"10.1177\/17534666241232561"},{"key":"e_1_3_7_144_1","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.1037"},{"key":"e_1_3_7_145_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-024-02861-w"},{"key":"e_1_3_7_146_1","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2019-0328TR"},{"key":"e_1_3_7_147_1","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2016-0217OC"},{"key":"e_1_3_7_148_1","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2014-0445OC"},{"key":"e_1_3_7_149_1","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2020.1773790"},{"key":"e_1_3_7_150_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.101.5.1326"},{"issue":"2","key":"e_1_3_7_151_1","first-page":"87","article-title":"Effects of gamma-interferon on collagen and histamine content in bleomycin-induced lung fibrosis in rats","volume":"12","author":"Okada T","year":"1993","unstructured":"Okada T, Sugie I, Aisaka K. Effects of gamma-interferon on collagen and histamine content in bleomycin-induced lung fibrosis in rats. Lymphokine Cytokine Res. 1993;12(2):87\u201391.","journal-title":"Lymphokine Cytokine Res"},{"key":"e_1_3_7_152_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02111-2018"},{"key":"e_1_3_7_153_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2024.10.042"},{"key":"e_1_3_7_154_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104766"},{"key":"e_1_3_7_155_1","doi-asserted-by":"publisher","DOI":"10.17925\/USPRD.2024.9.1.4"},{"key":"e_1_3_7_156_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01259-2015"},{"key":"e_1_3_7_157_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00245.2007"},{"key":"e_1_3_7_158_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcdt.2013.02.012"},{"key":"e_1_3_7_159_1","doi-asserted-by":"publisher","DOI":"10.1086\/523590"},{"key":"e_1_3_7_160_1","first-page":"A1521","article-title":"Preliminary baseline data from the teton phase 3 clinical trials of inhaled treprostinil in the treatment of idiopathic pulmonary fibrosis","volume":"207","author":"Nathan SD","year":"2023","unstructured":"Nathan SD, Behr J, Cottin V, et al. Preliminary baseline data from the teton phase 3 clinical trials of inhaled treprostinil in the treatment of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2023;207:A1521.","journal-title":"Am J Respir Crit Care Med"},{"key":"e_1_3_7_161_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.resinv.2021.04.011"},{"key":"e_1_3_7_162_1","doi-asserted-by":"publisher","DOI":"10.1111\/imj.14670"},{"key":"e_1_3_7_163_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202103-0714OC"},{"key":"e_1_3_7_164_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2015.11.005"},{"key":"e_1_3_7_165_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209909"},{"key":"e_1_3_7_166_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/key213"},{"key":"e_1_3_7_167_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2023.107329"},{"key":"e_1_3_7_168_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.871861"},{"key":"e_1_3_7_169_1","unstructured":"Clinical Trials.gov. Bethesda (MD): National Library of medicine (US). Identifier NCT06572384 a study of the efficacy and safety of Belimumab in adults with interstitial lung disease associated with connective tissue disease (BEconneCTD-ILD). [cited 2025 Jun; Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/results\/NCT06572384"},{"key":"e_1_3_7_170_1","unstructured":"A phase II investigator-initiated clinical trial of PAI-1 inhibitor (TM5614) for systemic sclerosis-associated interstitial lung disease under immunosuppressive treatment. p. jRCT2021230022."},{"key":"e_1_3_7_171_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2008.06.046"},{"key":"e_1_3_7_172_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-021-01608-1"},{"key":"e_1_3_7_173_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.163.1.9807061"},{"key":"e_1_3_7_174_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00073506"},{"key":"e_1_3_7_175_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.38702"},{"key":"e_1_3_7_176_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3565(24)38125-X"},{"key":"e_1_3_7_177_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00174914"},{"key":"e_1_3_7_178_1","doi-asserted-by":"publisher","DOI":"10.46497\/ArchRheumatol.2020.7381"},{"key":"e_1_3_7_179_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.978429"},{"key":"e_1_3_7_180_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.151322"},{"key":"e_1_3_7_181_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30330-1"}],"container-title":["Expert Review of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/1744666X.2025.2543473","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T04:18:30Z","timestamp":1766722710000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/1744666X.2025.2543473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,3]]},"references-count":180,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8,3]]}},"alternative-id":["10.1080\/1744666X.2025.2543473"],"URL":"https:\/\/doi.org\/10.1080\/1744666x.2025.2543473","relation":{},"ISSN":["1744-666X","1744-8409"],"issn-type":[{"value":"1744-666X","type":"print"},{"value":"1744-8409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,3]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierm20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierm20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-04-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}